
NYSEHealthcareMedical - Healthcare Information Services
最新数据
US$24.66
+US$0.33 · +1.36%
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
前收盘价
US$24.66
+US$0.33 · +1.36%
盘中时间采用ET。市场数据可能有所延迟。
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
日内区间
当前US$24.66
52周区间
当前US$24.66
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
持有
估值
100
深度低估
情绪
56
多空交织
风险
66
高风险
动量
42
中性
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.
日内区间
当前US$24.66
52周区间
当前US$24.66
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 9.65亿 USD | 9.31亿 USD | 9.62亿 USD | 10.8亿 USD | 11.18亿 USD |
| 销货成本 | 6.99亿 USD | 2.39亿 USD | 2.35亿 USD | 2.04亿 USD | 1.75亿 USD |
| 毛利 | 2.67亿 USD | 6.91亿 USD | 7.26亿 USD | 8.76亿 USD | 9.42亿 USD |
| 销售、一般及管理费用 | 2.22亿 USD | 1.6亿 USD | 1.36亿 USD | 1.32亿 USD | 1.51亿 USD |
| 营业费用 | 2.22亿 USD | 20.81亿 USD | 5.64亿 USD | 12.38亿 USD | 5.56亿 USD |
| 利息收入 | 156.1万 USD | 313万 USD | 823.3万 USD | 350万 USD | 3万 USD |
| 利息支出 | 4亿 USD | 3.26亿 USD | 3.33亿 USD | 3.03亿 USD | 2.67亿 USD |
| 折旧和摊销 | 4.48亿 USD | 4.36亿 USD | 4.26亿 USD | 4.16亿 USD | 4.12亿 USD |
| 营业利润 | 4505.8万 USD | −13.9亿 USD | 1.62亿 USD | −3.63亿 USD | 3.86亿 USD |
| 净利润 | −2.84亿 USD | −16.46亿 USD | −9169.7万 USD | −5.73亿 USD | 1.02亿 USD |
公司数据更新于 2026年10月11日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化,并非 GoAI 建议。
平均目标
US$52.00
上涨空间 110.87%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2024年9月23日 | 1:40 | — | — |
股票拆分 | 2015年7月13日 | 8:1 | — | — |
已生效 2024年9月23日
1:40
已生效 2015年7月13日
8:1
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1283.78万0.00%2.3万亿 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM657.44万0.01%787.4亿 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF359万0.00%954亿 USD0.05%US$235+0.80%
Vanguard Russell 2000 ETFVTWO222.79万0.01%180亿 USD0.06%US$112.66+0.50%
Schwab Fundamental U.S. Small Company Index ETFFNDA165.37万0.02%87.82亿 USD0.25%US$35.62+0.17%
Schwab U.S. Small-Cap ETFSCHA118.83万0.01%218.24亿 USD0.03%US$32.79+0.40%
iShares Micro-Cap ETFIWC74.17万0.06%13.17亿 USD0.60%US$183+0.11%
iShares Russell 2000 Growth ETFIWO63.56万0.00%139.17亿 USD0.24%US$356.78+0.94%
Vanguard Morningstar Total Stock Market ETFVTI
iShares Russell 2000 ETFIWM
Vanguard Extended Market ETFVXF
Vanguard Russell 2000 ETFVTWO
Schwab Fundamental U.S. Small Company Index ETFFNDA
Schwab U.S. Small-Cap ETFSCHA
iShares Micro-Cap ETFIWC
iShares Russell 2000 Growth ETFIWOAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。